Search Results - "Gualtierotti, R."

Updating on the pathogenesis of systemic lupus erythematosus by Gualtierotti, R, Biggioggero, M, Penatti, A.E, Meroni, P.L

“…Abstract Systemic lupus erythematosus (SLE) is a multi-organ autoimmune disease whose pathogenesis is multifactorial lying on genetic, environmental factors…”
Get full text

Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome by Cugno, M., Gualtierotti, R., Possenti, I., Testa, S., Tel, F., Griffini, S., Grovetti, E., Tedeschi, S., Salardi, S., Cresseri, D., Messa, P., Ardissino, G.

“…Summary Background Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy characterized by hemolysis, platelet consumption, and renal…”
Get full text

Evidence for a pathogenic role of extrafollicular, IL-10–producing CCR6⁺B helper T cells in systemic lupus erythematosus by Facciotti, F., Larghi, P., Bosotti, R., Vasco, C., Gagliani, N., Cordiglierif, C., Mazzarag, S., Ranzani, V., Rottoli, E., Curti, S., Penatti, A., Karnani, B., Kobayashi, Y., Crosti, M., Bombaci, M., van Hamburg, J. P., Rossetti, G., Gualtierotti, R., Gerosa, M., Gatti, S., Torretta, S., Pignataro, L., Tas, S. W., Abrignani, S., Pagani, M., Grassi, F., Meroni, P. L., Flavell, R. A., Geginat, J.

“…Interleukin 10 (IL-10) is an antiinflammatory cytokine, but also promotes B cell responses and plays a pathogenic role in systemic lupus erythematosus (SLE)…”
Get full text

COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia by Bandera, A., Aliberti, S., Gualtierotti, R., Baldini, M., Blasi, F., Cesari, M., Costantino, G., Fracanzani, A.L., Gori, A., Montano, N., Monzani, V., Nobili, A., Peyvandi, F., Pesenti, A., Prati, D., Valenti, L., Fusetti, G., Scudeller, L., Bosari, S., Bosari, S., Scudeller, L., Fusetti, G., Rusconi, L., Dell Orto, S., Prati, D., Valenti, L., Lamorte, G., Manunta, M., Baselli, G., Santoro, L., Gori, A., Bandera, A., Muscatello, A., Mangioni, D., Alagna, L., Bozzi, G., Lombardi, A., Ungaro, R., Itri, T., Ferroni, V., Pastore, V., Massafra, R., Rondolini, I., Peyvandi, F., Gualtierotti, R., Ferrari, B., Rossio, R., Corona, E., Rampi, N., Massimo, C., Montano, N., Vigone, B., Bellocchi, C., Fiorelli, E., Melli, V., Tobaldini, E., Blasi, F., Aliberti, S., Spotti, M., Simonetta, E., Terranova, L., Amati, F., Miele, C., Misuraca, S., D'Adda, A., Della Fiore, S., Di Pasquale, M., Contarini, M.M.M., Ori, M., Morlacchi, L., Rossetti, V., Gramegna, A., Pappalettera, M., Cavallini, M., Vigni, A., Vicenzi, M., Rota, I., Costantino, G., Solbiati, M., Furlan, L., Mancarella, M., Colombo, G., Fanin, A., Monzani, V., Rovellini, A., Barbetta, L., Billi, F., Folli, C., Baldini, M., Motta, I., Scaramellini, N., Fracanzani, A.L., Lombardi, R., Iuculano, F., Cesari, M., Proietti, M., Calcaterra, L., Nobili, A., Tettamanti, M., Monti, I.

Get full text

Smac127 Has Proapoptotic and Anti-Inflammatory Effects on Rheumatoid Arthritis Fibroblast-Like Synoviocytes by Casnici, Claudia, Marelli, Ornella, Corradini, Costantino, Ingegnoli, Francesca, Seneci, P., Crotta, Katia, Gualtierotti, Roberta, Lattuada, Donatella, Viganò, R.

“…Rheumatoid arthritis (RA) is characterized by synovial inflammation and hyperplasia. Fibroblast-like synoviocytes (FLSs) are apoptosis-resistant and contribute…”
Get full text

Hand impairment in systemic sclerosis: association of different hand indices with organ involvement by Ingegnoli, F, Boracchi, P, Ambrogi, F, Gualtierotti, R, Galbiati, V, Meroni, PL

“…Objective: To evaluate the association between the assessment tools used to quantify hand impairment and organ involvement in patients with systemic sclerosis…”
Get full text

Health related quality of life assessment in patients with systemic sclerosis by Gualtierotti, R, Scalone, L, Ingegnoli, F, Cortesi, P, Lubatti, C, Zeni, S, Meroni, P L

“…Health-related quality of life (HRQoL) in patients with systemic sclerosis (SSc), a chronic disabling disease associated to physical and psychological…”
Get full text

Nailfold capillaroscopic report: qualitative and quantitative methods by Lubatti, C, Ingegnoli, F, Gualtierotti, R, Boracchi, P, Zahalkova, L, Zeni, S, Soldi, A, Fantini, F

“…Nailfold capillaroscopy (NVC) is a simple and non-invasive method used for the assessment of patients with Raynaud's phenomenon (RP) and in the differential…”
Get full text

OC 24.3 Minimum Baseline FVIII Levels Required to Prevent Joint Bleeding Episodes: A Study in Mild Hemophilia A by Agosti, P., Siboni, S., Scardo, S., Gualtierotti, R., Peyvandi, F.

Get full text

Liver health in patients with hemophilia: Residual risk factors of liver-related complications after HCV-clearance by La Mura, V., Bitto, N., Capelli, C., Caputo, C., Siboni, S., Arcudi, S., Ciavarella, A., Gualtierotti, R., Fracanzani, A.L., Sangiovanni, A., Peyvandi, F.

“…HCV is highly prevalent in hemophilia. Nowadays DAA warrants 80-100% rate of sustained virological response (SVR) but no studies have described the clinical…”
Get full text

Exploring the prevalence and clinical impact of fibromyalgia syndrome in patients with shoulder diseases: a cross-sectional study by Compagnoni, Riccardo, Suffritti, Chiara, Fossati, Chiara, Zanini, Beatrice, Gerace, Filippo, Menon, Alessandra, Randelli, Pietro Simone, Gualtierotti, Roberta

“…Fibromyalgia (FM) is a musculoskeletal syndrome characterised by widespread chronic pain often associated with systemic manifestations such as mood…”
Get more information

PB0640 Safety and Efficacy of Combined Dual Antiplatelet Therapy and FVIII Prophylaxis in Hemophilia A Patients after the Acute Coronary Syndrome by Agosti, P., Siboni, S., Ciavarella, A., Arcudi, S., Boggio, F., Gualtierotti, R., Peyvandi, F.

Get full text

PB0667 Development and Clinical Utility of Anti-Emicizumab Antibody Detection Assays by Valsecchi, C., Schiavone, L., Arcudi, S., Gualtierotti, R., Novembrino, C., Beeg, M., Gobbi, M., Peyvandi, F.

Get full text

PCR191 Assessing Quality of Care in Haemophilia Using a Value-Based Healthcare Approach by Fornari, C., Cortesi, P.A., Conti, S., Pollio, B., Boccalandro, E., Buzzi, A., Carulli, C., Coppola, A., De Cristofaro, R., Di Minno, G., Dolan, G., Ferri Grazzi, E., Fornari, A., Gualtierotti, R., Hermans, C., Jiménez-Yuste, V., Kenet, G., Lupi, A., Martinoli, C., Mansueto, M.F., Nicolò, G., Tagliaferri, A., Gringeri, A., Molinari, A.C., Mantovani, L.G., Castaman, G.

Get full text

PB0663 Risk Factors for Atherosclerosis in Patients with Hemophilia by Ciavarella, A., Tafuri, F., Boggio, F., Abbattista, M., Arcudi, S., Gualtierotti, R., Mistretta, C., Nicolò, G., Siboni, S., Peyvandi, F.

Get full text

PB1239 Prophylaxis with Extended Half-life Products in Patients with Hemophilia A: Real-life Data of the Milan Cohort by Ciavarella, A., Truma, A., Ballardini, F., Abbattista, M., Arcudi, S., Gualtierotti, R., Mistretta, C., Nicolò, G., Novembrino, C., Siboni, S., Peyvandi, F.

Get full text

PB0683 Patients at Higher Risk of Spontaneous Joint Bleeding during Emicizumab Prophylaxis: A Study on Global Coagulation Assays and Arthropathy Scores by Arcudi, S., Gualtierotti, R., Scalambrino, E., Clerici, M., Hassan, S., Nicolò, G., Ciavarella, A., Begnozzi, V., Boccalandro, E., Siboni, S., Novembrino, C., Valsecchi, C., Peyvandi, F.

Get full text

OC 52.2 Residual Burden of Liver Disease After HCV-Clearance in Hemophilia: AWord of Caution in the Era of Gene Therapy by La Mura, V., Bitto, N., Capelli, C., Caputo, C., Siboni, S., Arcudi, S., Ciavarella, A., Gualtierotti, R., Fracanzani, A., Sangiovanni, A., Peyvandi, F.

Get full text

OC 60.4 Joint Damage in Patients Affected by Von Willebrand Disease: A Single-Center Experience by Gualtierotti, R., Arcudi, S., Giachi, A., Smania, M., Truma, A., Ciavarella, A., Begnozzi, V., Boccalandro, E., Biguzzi, E., Siboni, S., Peyvandi, F.

Get full text

Prothrombotic biomarkers in patients with rheumatoid arthritis: the beneficial effect of IL-6 receptor blockade by Gualtierotti, Roberta, Ingegnoli, Francesca, Griffini, Samantha, Grovetti, Elena, Meroni, Pier Luigi, Cugno, Massimo

“…The pro-inflammatory cytokine interleukin (IL)-6 is involved in the pathogenesis of both rheumatoid arthritis (RA) and cardiovascular events. We evaluated the…”
Get full text